Services

• Disease models
• Preclinical Safety and Toxicology models
• Pharmacokinetics models

Welcome to SBW/Toxis

Background

Toxis is a part of SBW Corporation performing preclinical in vivo pharmacology for drug discovery and development, biomaterials, food ingredient and chemical safety companies. SBW/Toxis core competencies are large spectrum of in in vivo disease models, safety pharmacology and toxicology, and pharmacokinetics studies. All Toxis studies are always tailored for the customer's need.

Mission statement

Our mission is to reduce time-to-market and cost-of-development of drugs by helping our customers • to understand the efficacy, kinetics and safety  of their lead molecules • to choose competent drug candidates timely and • improving success rate in the development

Ethics

We follow strictly the 3R principle of Reduce-Refine-Replace. Animal well-being is an intrinsic part of our daily work. Only human methods and euthanasia are used in our services.


Please follow this link to retrieve a brochure of SBW/Toxis knowledge and platforms